Daystar University Publications

Permanent URI for this community

https://repository.daystar.ac.ke/handle/123456789/2827

Browse

Browsing Daystar University Publications by Subject "A. sativum"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Efficacy of crude methanolic extracts of Allium sativum L. and Moringa stenopetala (Baker f.) Cufod. against Leishmania major
    (Int. J. Med. Arom. Plants, 2014-03) Gikonyo, Nicholas K.; Kinuthia, Geoffrey K.; Kabiru, Ephantus Wanjohi ; Anjili, Christopher O.; Kigondu, Elizabeth M.; Ngure, Veronica N.; Ingonga, Johnstone M.
    Leishmania major is a protozoan parasite responsible for cutaneous leishmaniasis (CL) in humans. CL is transmitted via a bite by infected female phlebotomine sand fly. Research on herbal therapy for leishmaniases is increasing globally because conventional drugs are costly, toxic and require a prolonged administration. In vitro and in vivo antileishmanial activities of dried Allium sativum (garlic) and Moringa stenopetala methanolic extracts against L. major were studied. Minimum inhibitory concentrations (MICs) of methanolic extracts of A. sativum (A) and M. stenopetala(M) against L. major were 3 and 5 mg/ml and IC50 of 863.12 and 1752.92 μg/ml respectively. The blend AM (1:1) hadIC50 of 372.1μg/ml and promastigotes’ viability of 71.03% compared to IC50 of 0.26 and 0.82μg/ml and promastigotes’viability of 18.41% and 12.22% for Pentostam and Liposomal amphotericin B respectively. Multiplication indices (MIs) of L. major amastigotes ranged from 43.67% to 45.93% after treatment with extracts A or M or blend AM at 125μg/ml and were significantly different (P < 0.05) from Liposomal amphotericin B at 12.5μg/ml. Oral extract A reduced significantly (P > 0.05) L. major caused foot pad lesions in BALB/c mice while oral extract M did not. Blend AM (ip) reduced the lesion sizes and its efficacy was close to Pentostam and Liposomal amphotericin B. Oral extract A had a high parasite reduction rate of 60.70% and average LDU of 0.22±0.15 compared to Pentostam at 66.40% and LDU of 0.18±0.08. In conclusion, methanolic extract of A. sativum showed anti-leishmanial activity both in vitro and in vivo and it decreased L. major caused foot pad lesions in BALB/c mice. Methanolic extracts of M. stenopetala (ip) reduced the amastigotes burden in spleens of BALB/c mice. A blend of garlic and moringa methanolic extracts (AM at 1:1) were active against L. major. The active ingredients in crude methanolic extracts of garlic and moringa plants should be established and tested against L. major when blended.
  • Thumbnail Image
    Item
    Toxicity and efficacy of aqueous crude extracts from Allium sativum, Callistemon citrinus and Moringa stenopetala against L. Major
    (Kabarak Journal of Research & Innovation, 2015) Gikonyo, Nicholas K.; Kinuthia, Geoffrey K.; Anjili, Christopher O.; Kabiru, Ephantus Wanjohi ; Kigondu, Elizabeth M.; Ingonga, Johnny M.
    Cutaneous leishmaniasis (CL) treatment involves pentavalent antimonials, amphotericin B, pentamidine, miltefosine among others. These drugs are toxic, costly, and require prolonged use. CL is a protozoan skin infection which may lead to disfiguring and stigmatization. In Kenya, CL is common in Baringo County where it is caused by Leishmania major and transmitted by infected female phlebotomine sand fly. Leishmaniases are common in poverty stricken areas where victims opt for local herbal therapies. Herbs used haven’t been tested scientifically to verify their toxicity and efficacy. The current study determines in vitro toxicity and in vivo efficacy of aqueous crude extracts of Moringa stenopetala, Callistemon citrinus, and Allium sativum against L. major. The IC50 of aqueous extracts against promastigotes ranged from 297μg/ml to 575μg/ml compared to Pentostam and liposomal amphotericin B with IC50 of 0.26μg/ml and 0.82μg/ml respectively. The viability of promastigotes upon exposure to extracts ranged from 52.55% to 60.57%. Similarly the IC50 of extracts against vero cells ranged between 467μg/ml to 2105μg/ml compared to 108μg/ml and 60μg/ml for pentostam and liposomal amphotericin B respectively. Orally administered A. sativum reduced L. major caused footpad lesions significantly (P < 0.05) when compared to control PBS. The efficacy of oral C. citrinus extracts (B) in reducing amastigotes in spleens of infected BALB/c mice was 82.99%, followed by oral M. stenopetala (A) at 66.96% and oral A. sativum (C) at 60.37% compared to pentostam and liposomal amphotericin B at 66.40% and 60.62% respectively. The difference between the mean total LDUs for aqueous oral C. citrinus extracts and control oral PBS was significant (P = 0.017). It was concluded that crude aqueous extracts of A. sativum, M. stenopetala, and C. citrinus show antileishmanial activity at low toxicity. Inclusion of garlic and moringa in the diets of people in leishmaniases foci should be emphasized.